Skip to main content

Table 2 Comparison among two strategies for severe asthma treatment concerning health care utilization, quality of life and asthma control (n = 64)

From: Cost-effectiveness analysis of a state funded programme for control of severe asthma

  year before ProAR year after ProAR  
Health care utilization per patient median (quartiles) median (quartiles) p*
   Regular specialist visits 0 (0/0) 9 (6/12) < 0.01
   Spirometries performed 1 (0/1) 2 (2/2) < 0.01
   Emergency/unscheduled visits 36 (6/120) 1 (0/3) < 0.01
   Hospitalizations 1 (0/2) 0 (0/0) < 0.01
Quality of life    
   Total AQLQ score 2 (2/3) 4 (3/6) < 0.01
Asthma control    
   ACQ scores 4 (3/5) 2 (0.6/3) < 0.01
   % of expected FEV1 69 (49/82) 76 (58/84) 0.560
   % of expected PEF 45 (34/66) 66 (49/83) < 0.01
  1. * Wilcoxon Signed Rank Test